ITMI20072429A1 - Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca - Google Patents

Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca

Info

Publication number
ITMI20072429A1
ITMI20072429A1 IT002429A ITMI20072429A ITMI20072429A1 IT MI20072429 A1 ITMI20072429 A1 IT MI20072429A1 IT 002429 A IT002429 A IT 002429A IT MI20072429 A ITMI20072429 A IT MI20072429A IT MI20072429 A1 ITMI20072429 A1 IT MI20072429A1
Authority
IT
Italy
Prior art keywords
celiac disease
compounds
inflammatory component
selective treatment
intestinal immune
Prior art date
Application number
IT002429A
Other languages
English (en)
Inventor
Sergio Baroni
Salvatore Bellinvia
Original Assignee
Giuliani Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Int Ltd filed Critical Giuliani Int Ltd
Priority to IT002429A priority Critical patent/ITMI20072429A1/it
Priority to PCT/EP2008/068265 priority patent/WO2009080828A2/en
Priority to US12/810,159 priority patent/US8153693B2/en
Priority to CA2708512A priority patent/CA2708512A1/en
Priority to BRPI0821331-3A priority patent/BRPI0821331A2/pt
Priority to JP2010538801A priority patent/JP2011507818A/ja
Priority to EA201001058A priority patent/EA201001058A1/ru
Priority to CN2011103980277A priority patent/CN102641279A/zh
Priority to PL08863709T priority patent/PL2222291T3/pl
Priority to CN2008801225541A priority patent/CN101969943A/zh
Priority to EP10188940A priority patent/EP2279733A3/en
Priority to EP08863709A priority patent/EP2222291B1/en
Priority to DK08863709.5T priority patent/DK2222291T3/da
Priority to AT08863709T priority patent/ATE550020T1/de
Priority to ES08863709T priority patent/ES2384361T3/es
Priority to AU2008339909A priority patent/AU2008339909A1/en
Priority to PT08863709T priority patent/PT2222291E/pt
Priority to SI200830659T priority patent/SI2222291T1/sl
Priority to HRP20120404AT priority patent/HRP20120404T1/hr
Priority to KR1020107016082A priority patent/KR20100103836A/ko
Priority to MX2010007033A priority patent/MX2010007033A/es
Priority to NZ586191A priority patent/NZ586191A/en
Publication of ITMI20072429A1 publication Critical patent/ITMI20072429A1/it
Priority to IL206226A priority patent/IL206226A0/en
Priority to ZA2010/04802A priority patent/ZA201004802B/en
Priority to US13/331,173 priority patent/US20120157417A1/en
Priority to CY20121100511T priority patent/CY1112821T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
IT002429A 2007-12-24 2007-12-24 Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca ITMI20072429A1 (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT002429A ITMI20072429A1 (it) 2007-12-24 2007-12-24 Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
MX2010007033A MX2010007033A (es) 2007-12-24 2008-12-23 Compuestos para el tratamiento selectivo del componente inmunoinflamatorio intestinal de la enfermedad celiaca.
AT08863709T ATE550020T1 (de) 2007-12-24 2008-12-23 Verbindungen zur selektiven behandlung der intestinalen, immunologisch bedingten komponente von zöliakie
CA2708512A CA2708512A1 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
BRPI0821331-3A BRPI0821331A2 (pt) 2007-12-24 2008-12-23 Compostos para tratamento seletivo do componente imunoinflamatório intestinal da doença celíaca
JP2010538801A JP2011507818A (ja) 2007-12-24 2008-12-23 セリアック病の腸内の免疫炎症性成分の選択的処置のための化合物
EA201001058A EA201001058A1 (ru) 2007-12-24 2008-12-23 Соединения для селективного лечения иммуно-воспалительной реакции в кишечнике, являющейся составляющей глютеновой болезни
CN2011103980277A CN102641279A (zh) 2007-12-24 2008-12-23 用于选择性治疗乳糜泻中肠免疫性炎症成分的化合物
PL08863709T PL2222291T3 (pl) 2007-12-24 2008-12-23 Związki do selektywnego leczenia jelitowego składnika immunozapalnego celiakii
CN2008801225541A CN101969943A (zh) 2007-12-24 2008-12-23 用于选择性治疗乳糜泻中肠免疫性炎症成分的化合物
EP10188940A EP2279733A3 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
EP08863709A EP2222291B1 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
DK08863709.5T DK2222291T3 (da) 2007-12-24 2008-12-23 Forbindelser til selektiv behandling af den intestinale immuno-inflammatoriske komponent af cøliaki
PCT/EP2008/068265 WO2009080828A2 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
ES08863709T ES2384361T3 (es) 2007-12-24 2008-12-23 Compuestos para el tratamiento selectivo del componente inmuno-inflamatorio intestinal de la enfermedad celiaca
KR1020107016082A KR20100103836A (ko) 2007-12-24 2008-12-23 셀리악병의 장 면역―염증 요소의 선택적 치료를 위한 화합물
PT08863709T PT2222291E (pt) 2007-12-24 2008-12-23 Compostos para o tratamento seletivo do componente intestinal imuno-inflamatório da doença celíaca
SI200830659T SI2222291T1 (sl) 2007-12-24 2008-12-23 Spojine za selektivno zdravljenje intestinalne imunoinflamatorne komponente celiakije
HRP20120404AT HRP20120404T1 (hr) 2007-12-24 2008-12-23 Spojevi za selektivno liječenje intestinalne imunoinflamatorne komponente celijakije
AU2008339909A AU2008339909A1 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
US12/810,159 US8153693B2 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
NZ586191A NZ586191A (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
IL206226A IL206226A0 (en) 2007-12-24 2010-06-07 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
ZA2010/04802A ZA201004802B (en) 2007-12-24 2010-07-07 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
US13/331,173 US20120157417A1 (en) 2007-12-24 2011-12-20 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
CY20121100511T CY1112821T1 (el) 2007-12-24 2012-06-06 Ενωσεις για την επιλεκτικη θεραπεια της εντερικης ανοσο-φλεγμονωδους συνιστωσας της κοιλιοκακης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002429A ITMI20072429A1 (it) 2007-12-24 2007-12-24 Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca

Publications (1)

Publication Number Publication Date
ITMI20072429A1 true ITMI20072429A1 (it) 2009-06-25

Family

ID=40315657

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002429A ITMI20072429A1 (it) 2007-12-24 2007-12-24 Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca

Country Status (23)

Country Link
US (2) US8153693B2 (it)
EP (2) EP2279733A3 (it)
JP (1) JP2011507818A (it)
KR (1) KR20100103836A (it)
CN (2) CN101969943A (it)
AT (1) ATE550020T1 (it)
AU (1) AU2008339909A1 (it)
BR (1) BRPI0821331A2 (it)
CA (1) CA2708512A1 (it)
CY (1) CY1112821T1 (it)
DK (1) DK2222291T3 (it)
EA (1) EA201001058A1 (it)
ES (1) ES2384361T3 (it)
HR (1) HRP20120404T1 (it)
IL (1) IL206226A0 (it)
IT (1) ITMI20072429A1 (it)
MX (1) MX2010007033A (it)
NZ (1) NZ586191A (it)
PL (1) PL2222291T3 (it)
PT (1) PT2222291E (it)
SI (1) SI2222291T1 (it)
WO (1) WO2009080828A2 (it)
ZA (1) ZA201004802B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
LT2396081T (lt) 2009-02-16 2017-09-11 Nogra Pharma Limited Alkilamido junginiai ir jų panaudojimas
JP5768131B2 (ja) * 2010-09-10 2015-08-26 ファーマゼル ゲーエムベーハー 結晶性５−アミノサリチル酸の製造方法
AU2013217933B2 (en) 2012-02-09 2017-11-30 Nogra Pharma Limited Methods of treating fibrosis
AU2013248397A1 (en) 2012-04-18 2014-10-02 Nogra Pharma Limited Methods of treating lactose intolerance
WO2019164874A1 (en) * 2018-02-20 2019-08-29 Western New England University Thiol isomerases inhibitors for the treatment and prevention of food allergies, allergic diseases, and inflammatory diseases
AU2020217884B2 (en) 2019-02-08 2025-02-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
CN113801126A (zh) * 2021-07-20 2021-12-17 云南大学 一种多取代吡啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1642885B1 (en) * 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
US7417037B2 (en) * 2004-01-20 2008-08-26 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
WO2006125293A1 (en) * 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.

Also Published As

Publication number Publication date
CY1112821T1 (el) 2016-02-10
US20120157417A1 (en) 2012-06-21
EA201001058A1 (ru) 2011-02-28
EP2279733A3 (en) 2011-03-23
EP2279733A2 (en) 2011-02-02
PL2222291T3 (pl) 2012-08-31
MX2010007033A (es) 2010-10-07
ZA201004802B (en) 2011-03-30
CN102641279A (zh) 2012-08-22
BRPI0821331A2 (pt) 2015-06-16
SI2222291T1 (sl) 2012-08-31
CN101969943A (zh) 2011-02-09
NZ586191A (en) 2012-06-29
WO2009080828A3 (en) 2009-10-01
US20100305077A1 (en) 2010-12-02
AU2008339909A1 (en) 2009-07-02
US8153693B2 (en) 2012-04-10
CA2708512A1 (en) 2009-07-02
KR20100103836A (ko) 2010-09-28
ATE550020T1 (de) 2012-04-15
EP2222291B1 (en) 2012-03-21
WO2009080828A2 (en) 2009-07-02
DK2222291T3 (da) 2012-06-25
IL206226A0 (en) 2010-12-30
JP2011507818A (ja) 2011-03-10
PT2222291E (pt) 2012-07-02
HRP20120404T1 (hr) 2012-06-30
ES2384361T3 (es) 2012-07-04
EP2222291A2 (en) 2010-09-01

Similar Documents

Publication Publication Date Title
IL206226A0 (en) Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
LTPA2019504I1 (lt) Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
LTC1869025I2 (lt) Piperazinu pakeisti benzotiofenai, skirti psichikos sutrikimų gydymui
NL2001175A1 (nl) Cokesoven reconstructie.
NO20074613L (no) Tricykliske nukleosidforbindelser for behandling av virale infeksjoner
EP2298304A3 (en) Carboline derivatives useful in the treatment of cancer
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
PT2034844T (pt) Método para o tratamento de síndrome do intestino irritável com predominância de diarreia
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
FR2933402B1 (fr) Procede de purification de 2,3,3,3-tetrafluoro-1-propene (hfo1234yf)
CY1114952T1 (el) Ενεργοποιητες θειενο[2,3-b]πυριδινοδιονης της αμρκ και θεραπευτικες χρησεις αυτων
MX2007004276A (es) 1,5-naftiridin-azolidinonas que tienen actividad antiproliferativa de cdk-1.
BRPI0815999A2 (pt) correia dentada contendo uma camada resistente e camada resistente assim obtida.
CY1115604T1 (el) Μακροκυκλικα παραγωγα ουριας και σουλφαμιδης ως αναστολεις των ταfια
EP2381944A4 (en) ANTIVIRAL COMPOUNDS, TREATMENT AND ASSAY
AP2910A (en) Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses
WO2010148121A3 (en) Benzothiazole derivatives
BRPI0808823A2 (pt) composição e método para tratar, reduzir, melhorar ou prevenir uma infecção.
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
BRPI0811557A2 (pt) composto, composição farmacêutica, método de tratamento ou profilaxia de uma condição inflamatória.
DE602006021526D1 (de) Gleitkörper für Kettensystem, Kettenführung, Kettenspanner und Kettensystem
BRPI0716400A2 (pt) produto refratÁrio queimado
WO2006125815A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
DK1849826T3 (da) Transparent polyolefingenstand, der er blevet udsat for varmebehandling
ITMI20051107A1 (it) Metodo per il trattamento del cancro